Showing results (121-130 of 639) with videos related to

Sort By:
Pageof 64
Anticancer Research|February 26, 2004
Loss of PTEN expression is not uncommon, but lacks prognostic value in stage I NSCLCKen Andre Olaussen, Jean-Charles Soria, Luc Morat, et al.
Translational Lung Cancer Research|July 23, 2021
Is there any opportunity for immune checkpoint inhibitor therapy in non-small cell lung cancer patients with brain metastases?Lizza E L Hendriks, Jordi Remon, Jessica Menis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 24, 2019
Antidrug Antibodies Against Immune Checkpoint Blockers: Impairment of Drug Efficacy or Indication of Immune Activation?Diego Enrico, Angelo Paci, Nathalie Chaput, et al.
Cancers|July 9, 2022
Radon and Lung Cancer: Current Trends and Future PerspectivesMariona Riudavets, Marta Garcia de Herreros, Benjamin Besse, et al.
Cancer Treatment Reviews|September 11, 2017
Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter?Roberto Ferrara, Laura Mezquita, Edouard Auclin, et al.
International Journal of Clinical Pharmacy|May 11, 2018
Olanzapine as antiemetic drug in oncology: a retrospective study in non-responders to standard antiemetic therapyFlorian Slimano, Florence Netzer, Isabelle Borget, et al.
Bulletin Du Cancer|November 23, 2011
[Renal insufficiency and breast cancer]Philippe Beuzeboc, Christophe Le Tourneau, Joseph Gligorov, et al.
Bulletin Du Cancer|March 23, 2013
[Management of brain metastases for lung cancer patients]Fabrice Barlesi, Natalia Khobta, Agnès Tallet, et al.
European Radiology|July 29, 2018
Intracardiac cement embolism during percutaneous vertebroplasty: incidence, risk factors and clinical managementSarah Fadili Hassani, Evelyne Cormier, Eimad Shotar, et al.
Pageof 64